Kura Oncology, Inc.
KURA · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | $750 | $1,053 | $831 | $929 |
| - Cash | $224 | $37 | $52 | $91 |
| + Debt | $17 | $17 | $14 | $7 |
| Enterprise Value | $543 | $1,033 | $794 | $845 |
| Revenue | $54 | $0 | $0 | $0 |
| % Growth | – | – | – | – |
| Gross Profit | $54 | -$1 | $0 | $0 |
| % Margin | 100% | – | – | – |
| EBITDA | -$169 | -$150 | -$135 | -$129 |
| % Margin | -314.6% | – | – | – |
| Net Income | -$174 | -$153 | -$136 | -$130 |
| % Margin | -322.9% | – | – | – |
| EPS Diluted | -2.02 | -2.08 | -2.03 | -1.97 |
| % Growth | 2.9% | -2.5% | -3% | – |
| Operating Cash Flow | $134 | -$125 | -$110 | -$105 |
| Capital Expenditures | -$0 | -$0 | -$1 | -$1 |
| Free Cash Flow | $134 | -$125 | -$111 | -$106 |